As of 2025-03-23, the Relative Valuation of Rapt Therapeutics Inc (RAPT) is (11.27) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.31 USD, the upside of Rapt Therapeutics Inc based on Relative Valuation is -960.0%.
The range of the Relative Valuation is (11.68) - (13.87) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 16.3x | 14.6x |
| Forward P/E multiples | 5.1x - 15.2x | 10.1x |
| Fair Price | (11.68) - (13.87) | (11.27) |
| Upside | -991.4% - -1158.5% | -960.0% |
| Date | P/E |